Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Research output: Contribution to journalArticle

Abstract

Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA.

Details

Authors
  • Karen Hambardzumyan
  • Rebecca Bolce
  • Saedis Saevarsdottir
  • Scott E Cruickshank
  • Eric H Sasso
  • David Chernoff
  • Kristina Forslind
  • Ingemar Petersson
  • Pierre Geborek
  • Ronald F van Vollenhoven
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Rheumatology and Autoimmunity
Original languageEnglish
Pages (from-to)1102-1109
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number6
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes